Federal
Register Notices > Notice of
Application - 2006
>
Johnson Matthey Inc.
FR Doc E6-21884 [Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices] [Page 77065] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22de06-110]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR),
this is notice that on November 15, 2006, Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066,
made application by letter to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of Remifentanil (9739), a basic class of
controlled substance listed in schedule II.
The company plans on producing this item for sale to its customers, who are
final dosage manufacturers.
Any other such applicant and any person who is presently registered with DEA
to manufacture such a substance may file comments or objections to the issuance
of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative/ODL; or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal Register
Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301;
and must be filed no later than February 20, 2007.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-21884 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|